Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Triple-Negative Breast Carcinoma|Unresectable Triple-Negative Breast Carcinoma
Interventions: BIOLOGICAL: Alpha-type-1 Polarized Dendritic Cells|PROCEDURE: Biopsy|PROCEDURE: Computed Tomography|PROCEDURE: Leukapheresis|BIOLOGICAL: Pembrolizumab|OTHER: Quality-of-Life Assessment
Sponsor: Roswell Park Cancer Institute